Skip to main content
Have a personal or library account? Click to login
Is the Oxidative Stress Really a Disease? Cover

References

  1. 1. Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;4:89-96.
  2. 2. Gülçin İ. Antioxidant activity of food constituents: an overview. Arch Toxicol. 2012;86(3):345-391.
  3. 3. Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzaniet R. Atherosclerosis and oxidative stress. Histol Histopathol. 2008;23:381-390.
  4. 4. Radi R. Peroxynitrite, a Stealthy Biological Oxidant. J Biol Chem. 2013;288:26464-26472.
  5. 5. Pacher P, Beckman JS, Liaudet L. Nitric Oxide and Peroxynitrite in Health and Disease. Physiol Rev. 2007;87:315-424.
  6. 6. Le Lay S, Simard G, Martinez MC, Andriantsitohaina1 R. Oxidative stress and metabolic pathologies: from an adipocentric point of view. Oxid Med Cell Longev. 2014;2014:908539.
  7. 7. Wilkie-Grantham RP, Magon NJ, Harwood DT, et al. Myeloperoxidase- Dependent Lipid Peroxidation Promotes the Oxidative Modification of Cytosolic Proteins in Phagocytic Neutrophils. J Biol Chem. 2015; doi/10.1074/jbc.M114.613422.
  8. 8. Aprioku JS. Pharmacology of Free Radicals and the Impact of Reactive Oxygen Species on the Testis. J Reprod Infertil. 2013;14:158-172.
  9. 9. Chen SX, Schopfer P. Hydroxyl-radical production in physiological reactions. A novel function of peroxidase. Eur J Biochem. 1999;260:726-735.
  10. 10. Lipinski B. Hydroxyl radical and its scavengers in health and disease. Oxid Med Cell Longev. 2011;2011:809696.
  11. 11. Valavanidis A, Vlahogianni T, Dassenakis M, Scoullos M. Molecular biomarkers of oxidative stress in aquatic organisms in relation to toxic environmental pollutants. Ecotoxicol Environ Saf. 2006;64:178-189.
  12. 12. Croitoru MD, Fülöp I, Fogarasi E (eds). Principii generale ale toxicologiei. University Press Tirgu Mureș. 2014;90-93.
  13. 13. Wu J, Xia S, Kalionis B, Wan W, Sun T. The role of oxidative stress and inflammation in cardiovascular aging. Biomed Res Int. 2014;2014:615312.
  14. 14. Veselá A, Wilhelm J. The Role of Carbon Dioxide in Free Radical Reactions of the Organism. Physiol Res. 2002;51:335-339.
  15. 15. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52:601-623.
  16. 16. Micallef M, Lexis L, Lewandowski P. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr J. 2007;6:27.
  17. 17. Imazato T, Shiokawa A, Kurose Y, et al. Determination of 4-hydroxy-2-nonenal in serum by high-performance liquid chromatography with fluorescence detection after pre-column derivatization using 4-(N,Ndimethylaminosulfonyl)-7-hydrazino-2, 1,3-benzoxadiazole. Biomed Chromatogr. 2014;28:858-861.
  18. 18. Liu YM, Jinno H, Kurihara M, Miyata N, Toyo’oka T. Determination of 4-hydroxy-2-nonenal in primary rat hepatocyte cultures by liquid chromatography with laser induced fluorescence detection. Biomed Chromatogr. 1999;13:75-80.
  19. 19. http://www.atsdr.cdc.gov/toxprofiles/tp124-c7.pdf, accesed on 2015 february.
  20. 20. Paci A, Rieutord A, Guillaume D, et al. Quantitative high-performance liquid chromatographic determination of acrolein in plasma after derivatization with Luminarin 3. J Chromatogr B Biomed Sci Appl. 2000;739:239-246.
  21. 21. WHO 2002, http://www.who.int/ipcs/publications/cicad/en/cicad43.pdf, accesed on 2015 february.
  22. 22. Lehtonen P, Raimo Laakso R, Puputti E. Liquid chromatographic determination of 2-propenal (acrolein) and 2-butenal (crotonaldehyde) from qater-ethanol mixtures. Z Lebensm Unters Forsch. 1984;178:487-489.
  23. 23. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329:23-38.
  24. 24. Wen JJ, Gupta S, Guan Z, et al. Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats. J Am Coll Cardiol. 2010;55:2499-2508.
  25. 25. Castegna A, Drake J, Pocernich C, Butterfield DA. Protein Carbonyl Levels-An Assessment of Protein Oxidation, in Hensley K, Floyd RA (eds): Methods in Biological Oxidative Stress. Humana Press, Totowa USA, 2003;161-168.
  26. 26. Sultana R, Cenlni G, Butterfield DA. Biomarkers of oxidative stress in neurodegenerative diseases, in Villamena FA (ed): Molecular basis of oxidative stress. John Wiley&Sons, New Jersey Canada, 2013;359-376.
  27. 27. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2’ -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27:120-139.
  28. 28. Ferrante G, Nakano M, Prati F, et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation. 2010;122:2505-2513.
  29. 29. The Journal of Nutrition, http://associatesofmax.com/PubMed/AmericanSocietyforNutritionalSciences.pdf, accesed on 2015 february.
  30. 30. Arbor Assays, http://www.arborassays.com/documentation/inserts/K006-H1.pdf, accesed on 2015 february.
  31. 31. Chandramohan G, Khalid S Al-Numair KS, Pugalendi KV. Restoration of altered plasma, erythrocyte and liver antioxidant levels by 3-hydroxymethyl xylitol in streptozotocin-diabetic rats. IJIB. 2009;5:176-181.
  32. 32. Oxford Biomedical Research, GSH/GSSG Assay, http://www.oxfordbiomed.com/gshgssg-assay-1, accesed on 2015 february.
  33. 33. Akerboom TP, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981;77:373-382.
  34. 34. Dojindo Molecular Technologies, GSSG/GSH Quantification Kit, http://www.dojindo.com/store/p/824-GSSG-GSH-Quantification-Kit.html, accesed on 2015 february.
  35. 35. BioVision Incorporated, http://www.biovision.com/search/results.html?keywords=glutathione+assay&x=0&y=0&gclid=CLnepyZrcQCFSzKtAodAU0ADw, accesed on 2015 february.
  36. 36. Vehvilainen P, Koistinaho J, Gundars G. Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis. Front Cell Neurosci. 2014;8:126.
  37. 37. Notas G, Koutroubakis IE, Kouroumalis A. Oxidants and antioxidants in liver disease, in Panglossi H (ed): Antioxidants-New Research. Nova Science Publishers, New York, 2006;1-36.
  38. 38. Odajima N, Betsuyaku T, Nagai K, et al. The Role of Catalase in Pulmonary Fibrosis. Respiratory Research. 2010;11:183.
  39. 39. Ballatori N, Krance SM, Notenboom S, et al. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009;390:191-214.
  40. 40. Clinical Nutrition Insights, http://acudoc.com/Antioxidants.PDF, accesed on 2015 february.
  41. 41. Rahal A, Kumar A, Singh V, et al. Oxidative stress, prooxidants, and antioxidants: the interplay, Biomed Res Int. 2014;2014: 61264.
  42. 42. Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot. 2003;91:179-194.
  43. 43. Rodella LF, Favero G. Atherosclerosis and Current Anti-Oxidant Strategies for Atheroprotection, in Rita Rezzani (ed): Current Trends in Atherogenesis. InTech, 2013, DOI: 10.5772/56246.
  44. 44. Blanco-Ayala T, Lugo-Huitrón R, Serrano-López EM, et al. Antioxidant properties of xanthones from Calophyllum brasiliense: prevention of oxidative damage induced by FeSO₄. BMC Complement Altern Med. 2013;13:262.
  45. 45. Wen JJ, Bhatia V, Popov VL, Garg NJ. Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas’ disease. Am J Pathol. 2006;169(6):1953-1964.
  46. 46. Bath PM, Gray LJ, Bath AJ, et al. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. Br J Pharmacol. 2009;157:1157-1171.
  47. 47. Kennedy RL, Zivin JA, Ashwood T, et al. NXY-059 for Acute Ischemic Stroke. N Engl J Med. 2006;354:588-600.
  48. 48. Ashfaq Shuaib A, Kennedy RL, Lyden P, et al. NXY-059 for the Treatment of Acute Ischemic Stroke. N Engl J Med. 2007;357:562-571.
  49. 49. Ley JJ, Prado R, Wei JQ, et al. Neuroprotective antioxidant STAZN protects against myocardial ischemia/reperfusion injury. Biochem Pharmacol. 2008;75:448-456.
  50. 50. Ley JJ, Belayev L, Saul I, Becker DA, Ginsberg MD. Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window. Brain Res. 2007;1180:101-110.
DOI: https://doi.org/10.1515/amma-2015-0070 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Language: English
Page range: 112 - 120
Submitted on: Mar 30, 2015
Accepted on: Jun 4, 2015
Published on: Feb 9, 2016
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Erzsébet Fogarasi, Mircea Dumitru Croitoru, Ibolya Fülöp, Daniela-Lucia Muntean, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.